Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

Leeds Hospitals Move to Fully Digital Pathology for Diagnosis

Published: 

UNITED KINGDOM, DECEMBER 19th, 2017. Leeds Teaching Hospitals NHS Trust/University of Leeds has successfully transitioned its first subspeciality pathology services to fully digital reads, instead of microscopes. This conversion represents a key step in their partnership with Leica Biosystems. The Leeds team is now reporting over 99% of their cases using digital pathology, only reverting to microscopes for exceptional cases.

“The positive feedback on digital from our pathologists has been overwhelming,” said Consultant Pathologist and head of Leeds Digital Pathology Group, Dr. Darren Treanor. “In our initial group, we had both self-declared digital enthusiasts and sceptics. Following the validation, they have transitioned to using digital pathology over traditional microscopy, commenting on the speed and accuracy of tissue measurements, as well as faster access to slides.”

“The results from Leeds demonstrate the advantages of mainstream adoption of digital pathology,” stated Jerome Clavel, Vice President and General Manager of Leica Biosystems Pathology Imaging Business. Our comprehensive digital pathology solutions enable customers in countries where labeling includes clinical IVD use to streamline the diagnosis process in a cost-effective manner. This can help anxious patients to get a diagnosis faster.”

“We decided to embark on full adoption of digital pathology by validating our subspecialities in sequence,” said Dr. Bethany Williams, Digital Pathology Fellow at Leeds Hospital. “We are on track to go fully digital with all immunohistochemistry (IHC) by the end of 2017. At the end of 2018, the entire department will be 100% digital.”

The clinical use claims described in the information provided have not been cleared or approved by the U.S. FDA nor are the products available in the United States.

About Leica Biosystems
Leica Biosystems is a global leader in workflow solutions and automation. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries. It has manufacturing facilities in 9 countries, sales and service organizations in 19 countries, and an international network of dealers. The company is headquartered in Nussloch, Germany. Visit LeicaBiosystems.com for more information.

About University of Leeds
University of Leeds is one of the largest higher education institutions in the UK, with more than 33,000 students from more than 150 different countries, and a member of the Russell Group of research-intensive universities. We are a top ten university for research and impact power in the UK, according to the 2014 Research Excellence Framework, and are in the top 100 for academic reputation in the QS World University Rankings 2018. Additionally, the University was awarded a Gold rating by the Government’s Teaching Excellence Framework in 2017, recognizing its ‘consistently outstanding’ teaching and learning provision. Twenty-four of our academics have been awarded National Teaching Fellowships – more than any other institution in England, Northern Ireland and Wales – reflecting the excellence of our teaching.

Follow University of Leeds or tag us in to coverage
Twitter
Facebook
LinkedIn

About Leeds Teaching Hospitals NHS Trust
The Leeds Teaching Hospitals NHS Trust is one of the largest in England and includes two major teaching hospitals, Leeds General Infirmary and St James’s University Hospital. It has a total budget of over £1.1 billion, employs more than 16,000 staff across seven main sites, and treats around 1.5 million patients a year.

Digital Pathology Powerwall